Eucreas Eiropas Savienība - latviešu - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Eiropas Savienība - latviešu - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 un 5. 1 pieejamo datu par dažādām kombinācijām).

Zomarist Eiropas Savienība - latviešu - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformīns hidrohlorīds - cukura diabēts, 2. tips - cukura diabēts - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Fasenra Eiropas Savienība - latviešu - EMA (European Medicines Agency)

fasenra

astrazeneca ab - benralizumabs - astma - zāles obstruktīvu elpceļu slimību, - fasenra ir norādīts, kā pievienot uz tehniskās apkopes ārstēšana pieaugušiem pacientiem ar smagu eosinophilic astmas nepietiekami kontrolē, neskatoties uz lielu devu inhalējamo kortikosteroīdu plus ilgstošas darbības beta agonistus.

Vilspox 50 mg/850 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

vilspox 50 mg/850 mg apvalkotās tabletes

sandoz d.d., slovenia - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Daltex 50 mg/850 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

daltex 50 mg/850 mg apvalkotās tabletes

medochemie ltd., cyprus - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Daltex 50 mg/1000 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

daltex 50 mg/1000 mg apvalkotās tabletes

medochemie ltd., cyprus - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Vilspox 50 mg/1000 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

vilspox 50 mg/1000 mg apvalkotās tabletes

sandoz d.d., slovenia - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg

Vildagliptin/Metformin Teva 50 mg/850 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

vildagliptin/metformin teva 50 mg/850 mg apvalkotās tabletes

teva b.v., netherlands - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/850 mg

Vildagliptin/Metformin Teva 50 mg/1000 mg apvalkotās tabletes Latvija - latviešu - Zāļu valsts aģentūra

vildagliptin/metformin teva 50 mg/1000 mg apvalkotās tabletes

teva b.v., netherlands - vildagliptinum, metformini hydrochloridum - apvalkotā tablete - 50 mg/1000 mg